Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Eledon Pharmaceuticals ( (ELDN) ) has issued an update.
Eledon Pharmaceuticals announced an amendment to the employment agreement of its CEO, David-Alexandre Gros, adjusting the market value cap for his performance bonus. The CEO’s bonus structure has been altered, allowing for a maximum bonus of $15 million if the company’s market value reaches $1.5 billion, with linear interpolation determining payouts between set thresholds.
More about Eledon Pharmaceuticals
YTD Price Performance: 134.44%
Average Trading Volume: 491,893
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $252.1M
For detailed information about ELDN stock, go to TipRanks’ Stock Analysis page.